Researchers in the Division of Cancer Research are on the vanguard of cancer biology, investigating:
- How patients’ genes play a role in their cancer risk.
- What causes cancer and cancer metastasis.
- How cancer cells communicate with the neighboring normal cells.
- The epigenetic changes that play a role in developing drug resistance.
- Discovering new ways to harness the immune system to fight cancer.
- Identifying new targets for companion diagnostics with treatments that reduce side effects
Our collaborative approach harnesses expertise in cutting edge sciences to bring us closer to finding a cure for cancers that cause human mortality — like the metastatic forms of breast and prostate cancer — and the rapidly progressing types of pancreatic, lung, ovarian and head and neck cancers.
Cancer Division Faculty
-
Dr. Deborah A. Altomare
- Title: Associate Professor & Director of Transgenic Facility
- Office: BBS 342
- Phone: 407-266-7040
- Investigating Akt signaling and immune cell therapy in xenograft models of ovarian and pancreatic cancer
- Send an Email
-
Dr. Claudia Andl
- Title: Associate Professor
- Office: BMS 223A
- Phone: 407.823.1147
- Send an Email
-
Dr. Karl X. Chai
- Title: Associate Professor
- Office: BMS 323
- Phone: 407.823.6122
- Investigating ErbB receptor tyrosine kinases in cancer and modulation by membrane-bound serine proteases
- Send an Email
-
Dr. Ratna Chakrabarti
- Title: Associate Professor
- Office: Biomedical Research Annex (BRA) 140
- Phone: 407.882.2258
- Discovering how non-coding RNAs mediate androgen receptor function and drug resistance in prostate cancer
- Send an Email
-
Dr. Li-Mei Chen
- Title: Research Associate Professor & BMS Core Manager
- Office: BMS 324
- Phone: 407.823.3585
- Membrane-bound serine proteases and their inhibitors in tumor inflammation and progression
- Send an Email
-
Dr. Alicja Copik
- Title: Research Assistant Professor and Core Scientist
- Office: BBS 354
- Phone: 407.266.7132
- Nanoparticle-based stimulation of NK cells and active directing of innate immunity for cancer immunotherapy
- Send an Email
-
Dr. Annette Khaled
- Title: Professor & Cancer Division Head
- Office: BBS 355
- Phone: 407.266.7035
- Developing personalized treatments, harnessing nanomedicine and immunotherapy for metastatic cancers
- Send an Email
-
Dr. Jihe Zhao
- Title: PhD Program Coordinator & Associate Professor
- Office: BBS 303 (Lab) / BBS 316 (Office)
- Phone: 407.266.7099
- Send an Email
Cancer Affiliated Faculty
Dr. Priya Vishnubhotla, M.D.
Chief of Oncology, Orlando Veterans Affairs Medical Center